Erlotinib and the Risk of Oral Cancer
Interview with William N. William Jr, MD, and Scott M. Lippman, MD, author of Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial
lystn.fm © 2025.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS.